Astera Labs, Inc.
ALAB
$120.31
$0.410.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 115.13% | 136.51% | 163.80% | 200.19% | 242.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.13% | 136.51% | 163.80% | 200.19% | 242.24% |
| Cost of Revenue | 121.46% | 159.83% | 184.84% | 218.73% | 160.21% |
| Gross Profit | 113.17% | 129.79% | 157.63% | 194.70% | 279.19% |
| SG&A Expenses | -22.99% | -4.77% | 22.72% | 68.24% | 506.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.54% | 49.29% | 70.77% | 99.39% | 252.64% |
| Operating Income | 249.42% | 199.46% | 142.19% | 76.68% | -293.48% |
| Income Before Tax | 366.76% | 283.33% | 201.24% | 123.66% | -256.36% |
| Income Tax Expenses | -159.71% | -506.93% | -385.03% | -233.44% | -50.35% |
| Earnings from Continuing Operations | 362.68% | 311.99% | 212.11% | 140.66% | -217.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 362.68% | 311.99% | 212.11% | 140.66% | -217.71% |
| EBIT | 249.42% | 199.46% | 142.19% | 76.68% | -293.48% |
| EBITDA | 259.64% | 206.79% | 147.64% | 80.16% | -307.39% |
| EPS Basic | 176.73% | 180.41% | 139.88% | 112.44% | -129.28% |
| Normalized Basic EPS | 184.60% | 168.00% | 138.41% | 107.18% | -136.18% |
| EPS Diluted | 170.42% | 173.79% | 136.31% | 110.67% | -132.09% |
| Normalized Diluted EPS | 178.28% | 162.83% | 135.48% | 106.14% | -137.18% |
| Average Basic Shares Outstanding | 26.91% | 62.68% | 127.36% | 284.43% | 253.16% |
| Average Diluted Shares Outstanding | 32.45% | 77.18% | 143.30% | 304.15% | 265.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |